UpdatesPress Release
Eris Lifesciences partnered with Natco Pharma to launch transformative drug Semaglutide in India, strengthening its diabetes & metabolic care portfolio.
Eris Lifesciences LimitedERIS · Filed with the exchange
Targeting Type 2 diabetes & weight management, launch is expected soon.
No comments yet. Be the first.